Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

Sucralfate is a complex of sulfated sucrose and aluminum hydroxide used as a mucosal protective agent for peptic ulcers. In acidic conditions, sucralfate dissociates into an aluminum salt and negatively charged sucrose sulfate. These components bind to positively charged protein groups at the ulcer site, creating a viscous, cross-linked polymer that adheres to epithelial cells and forms a protective barrier.

Sucralfate forms an extensively cross-linked, viscous polymer that binds to epithelial cells at the ulcer site. This sticky polymer creates a protective barrier that limits acid and pepsin access to the damaged tissue. By blocking these harmful substances, sucralfate reduces further mucosal protein digestion and promotes natural ulcer healing.

Pepsin is a digestive enzyme that damages the gastric mucosa when the mucus-bicarbonate barrier is weakened by excessive acid secretion. Once pepsin accesses epithelial cells, it digests mucosal proteins, causing mucosal erosion and ulcer formation. Cytoprotective agents like sucralfate inhibit this pepsin-mediated protein digestion to prevent further tissue damage.

Sucralfate triggers prostaglandin production at the ulcerative site. Prostaglandins then stimulate the secretion of mucus and bicarbonate ions, which are essential components of the mucus-bicarbonate barrier. This additional cytoprotective action strengthens mucosal defense mechanisms and contributes to overall healing and protection of the ulcerated area.

The mucus-bicarbonate barrier is a natural defense mechanism that protects the gastric mucosa from acid and pepsin damage. Mucus provides a physical layer while bicarbonate ions neutralize acid. When excessive acid secretion disrupts this barrier, pepsin can access epithelial cells and cause mucosal erosion. Sucralfate helps restore this barrier by promoting mucus and bicarbonate secretion.

Cytoprotective agents like sucralfate protect mucosal cells by forming barriers, stimulating prostaglandin production, and enhancing mucus and bicarbonate secretion. Unlike acid suppressive drugs that reduce acid production, cytoprotective agents work by strengthening mucosal defense mechanisms and promoting healing even in the presence of acid.

Sucralfate dissociates in acidic conditions to release negatively charged sucrose sulfate, which binds electrostatically to positively charged groups on proteins at the ulcer site. This ionic interaction creates an extensively cross-linked, viscous polymer that adheres strongly to epithelial cells, forming a durable protective barrier that resists acid and pepsin penetration.